After 50 years of clinical nutrition experience and Mycology (fungus) research, I am 100% convinced that fungi and their poisonous byproducts are killing we Americans at a very, very rapid pace. It seems that their death certificates represent only the symptoms they had before death, but the cause of their death is rarely reduced to writing.
As symptoms continue being chemically stabilized by medications, the underlying pathology of the disease that is causing these symptoms remain elusive. When fungus is “the cause” of the disease, if it is never addressed and eliminated it is free to disseminate through the human body and wreak havoc within any tissue or organ it grows in. Sometimes, the same mycotoxins (fungal poisons) that disrupt the pancreatic beta cells enabling diabetes symptoms, later become the brain plaque that will be diagnosed as “Alzheimer’s disease.”
A case in point is a new paper that (1) expounds on how a class of diabetes drugs called “sulfonylureas,” that have been used for years to help people with Type 2 diabetes are now helping patient with Alzheimer’s disease. I wonder why?
What is my take on this? WELL, OF COURSE sulfonylurea’s help both diabetes patients and Alzheimer’s patients, because both diseases have been linked to fungus for a long time, unbeknownst to our brightest and best. As researchers continue scratching their heads trying to figure out why a diabetes drug would help Alzheimer’s sufferers, while simultaneously petitioning for more grant money, the simple answer may lie in this ten-year-old research paper (2).
Why might sulfonylurea’s effectively treat both disorders. Simply put, the paper says that, the sulfonylureas that were tested inhibited and killed fungi.
Doug’s hypothesis, indeed, but when I’m long gone, remember these words!